Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- Check2 days agoChange DetectedThe Record History now includes a new revision entry (v3.7.0) and removes the older revision (v3.6.6) from the list, reflecting an update to the study record versions.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision, v3.6.6, was added to the study history, replacing the previous v3.6.5 and indicating the record has been updated. This reflects a metadata update to the page rather than a change to the study results.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.6.5 is added to the Record History and the previous revision v3.6.4 is removed, indicating an updated release/history entry for the study page.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.6.4 now appears in the record history, replacing Revision: v3.6.3.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

- Check88 days agoChange DetectedThe study record history now includes a new revision entry for v3.6.2. The previous v3.6.0 entry has been removed.SummaryDifference0.1%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.